<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">JBC</journal-id>
<journal-id journal-id-type="hwp">spjbc</journal-id>
<journal-title>Journal of Bioactive and Compatible Polymers</journal-title>
<issn pub-type="ppub">0883-9115</issn>
<issn pub-type="epub">1530-8030</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage UK: London, England</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0883911512467643</article-id>
<article-id pub-id-type="publisher-id">10.1177_0883911512467643</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Studies on the biocompatibility of bacterial cellulose</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Andrade</surname><given-names>Fábia K</given-names></name>
<xref ref-type="aff" rid="aff1-0883911512467643">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Alexandre</surname><given-names>Nuno</given-names></name>
<xref ref-type="aff" rid="aff2-0883911512467643">2</xref>
<xref ref-type="aff" rid="aff3-0883911512467643">3</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Amorim</surname><given-names>Irina</given-names></name>
<xref ref-type="aff" rid="aff4-0883911512467643">4</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Gartner</surname><given-names>Fátima</given-names></name>
<xref ref-type="aff" rid="aff4-0883911512467643">4</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Maurício</surname><given-names>Ana Colette</given-names></name>
<xref ref-type="aff" rid="aff5-0883911512467643">5</xref>
<xref ref-type="aff" rid="aff6-0883911512467643">6</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Luís</surname><given-names>Ana Lúcia</given-names></name>
<xref ref-type="aff" rid="aff5-0883911512467643">5</xref>
<xref ref-type="aff" rid="aff6-0883911512467643">6</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Gama</surname><given-names>Miguel</given-names></name>
<xref ref-type="aff" rid="aff1-0883911512467643">1</xref>
</contrib>
</contrib-group>
<aff id="aff1-0883911512467643">
<label>1</label>IBB-Institute for Biotechnology and Bioengineering, Centre of Biological Engineering, University of Minho, Braga, Portugal</aff>
<aff id="aff2-0883911512467643">
<label>2</label>Departamento de Zootecnia, Universidade de Évora, Évora, Portugal</aff>
<aff id="aff3-0883911512467643">
<label>3</label>ICAAM-Instituto de Ciências Agro-Ambientais Mediterrânicas, Universidade de Évora, Évora, Portugal</aff>
<aff id="aff4-0883911512467643">
<label>4</label>Department of Pathology and Molecular Immunology, Institute of Biomedical Sciences Abel Salazar (ICBAS), Porto University, Porto, Portugal</aff>
<aff id="aff5-0883911512467643">
<label>5</label>Animal Science and Study Centre (CECA)/Food and Agrarian Sciences and Technologies Institute (ICETA), Porto University, Porto, Portugal</aff>
<aff id="aff6-0883911512467643">
<label>6</label>Department of Veterinary Clinics, Institute of Biomedical Sciences Abel Salazar (ICBAS), Porto University, Porto, Portugal</aff>
<author-notes>
<corresp id="corresp1-0883911512467643">Miguel Gama, IBB-Institute for Biotechnology and Bioengineering, Centre of Biological Engineering, University of Minho, Campus of Gualtar, 4710-057 Braga, Portugal. Email: <email>fmgama@deb.uminho.pt</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>1</month>
<year>2013</year>
</pub-date>
<volume>28</volume>
<issue>1</issue>
<fpage>97</fpage>
<lpage>112</lpage>
<permissions>
<copyright-statement>© The Author(s) 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<abstract>
<p>Bacterial cellulose was functionalized with a chimeric protein containing a cellulose-binding module and the adhesion peptide Arg-Gly-Asp. Small-diameter bacterial cellulose membranes were produced and subcutaneously implanted in sheep for 1–32 weeks. The implants triggered a biological response similar to other high surface-to-volume implants. There were no significant differences in the inflammation degree between the bacterial cellulose coated with the recombinant protein Arg-Gly-Asp–cellulose-binding module and the native bacterial cellulose. The implants were considered to be mildly irritating to the tissue compared to the negative control sample (expanded polytetrafluoroethylene). The analysis of the fluorescence microscopy revealed that, apart from increasing cell adhesion, the presence of Arg-Gly-Asp stimulated an even cell distribution, while the cells on the untreated bacterial cellulose seemed to form aggregates. Furthermore, the cells on the Arg-Gly-Asp–treated bacterial cellulose presented a more elongated morphology. Mechanical tests indicated that the small-diameter bacterial cellulose tubes were more elastic than the human arteries and veins.</p>
</abstract>
<kwd-group>
<kwd>Bacterial cellulose</kwd>
<kwd>bacterial cellulose biocompatibility</kwd>
<kwd>tissue engineering</kwd>
<kwd>cell adhesion</kwd>
<kwd>mechanical properties</kwd>
<kwd>adhesion peptide Arg-Gly-Asp</kwd>
<kwd>arteries and veins</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section1-0883911512467643" sec-type="intro">
<title>Introduction</title>
<p>The aim of tissue engineering and regenerative medicine is to promote regeneration of diseased or damaged human tissues. Biomaterials are used to build scaffolds in which cells and/or growth factors are seeded, cultured and then implanted to induce and direct the growth of new healthy tissue.<sup><xref ref-type="bibr" rid="bibr1-0883911512467643">1</xref></sup> Among the biomaterials used, natural polymers represent one of the most attractive options; they are similar to biological macromolecules and are expected to have better biocompatibility. Although several groups described the successful production of tissue-engineered blood vessels,<sup><xref ref-type="bibr" rid="bibr2-0883911512467643">2</xref>
<xref ref-type="bibr" rid="bibr3-0883911512467643"/><xref ref-type="bibr" rid="bibr4-0883911512467643"/><xref ref-type="bibr" rid="bibr5-0883911512467643"/><xref ref-type="bibr" rid="bibr6-0883911512467643"/>–<xref ref-type="bibr" rid="bibr7-0883911512467643">7</xref></sup> it must be recognized the cost and length of time required for the production of functional tissue. The long culture time required brings about the question of safety, due to possible cell differentiation. Therefore, using a biomaterial with good mechanical properties that favour cell colonization may provide a ‘mixed’ tissue-engineered/artificial prosthesis approach, allowing a prompt utilization and good tissue integration.</p>
<p>Bacterial cellulose (BC), a pure form of cellulose secreted by bacteria, such as <italic>Gluconacetobacter xylinus</italic>, has unique properties, including high water-holding capacity, high crystallinity, ultrafine fibre network, high tensile strength (TS) and the possibility to be shaped into three-dimensional (3D) structures during synthesis.<sup><xref ref-type="bibr" rid="bibr8-0883911512467643">8</xref></sup> These features make BC a promising material for the production of scaffolds in tissue engineering. In fact, several researchers have proposed BC as a scaffold for cartilage,<sup><xref ref-type="bibr" rid="bibr9-0883911512467643">9</xref>,<xref ref-type="bibr" rid="bibr10-0883911512467643">10</xref></sup> wound dressing,<sup><xref ref-type="bibr" rid="bibr11-0883911512467643">11</xref>
<xref ref-type="bibr" rid="bibr12-0883911512467643"/>–<xref ref-type="bibr" rid="bibr13-0883911512467643">13</xref></sup> dental implants,<sup><xref ref-type="bibr" rid="bibr14-0883911512467643">14</xref>
<xref ref-type="bibr" rid="bibr15-0883911512467643"/><xref ref-type="bibr" rid="bibr16-0883911512467643"/><xref ref-type="bibr" rid="bibr17-0883911512467643"/><xref ref-type="bibr" rid="bibr18-0883911512467643"/><xref ref-type="bibr" rid="bibr19-0883911512467643"/>–<xref ref-type="bibr" rid="bibr20-0883911512467643">20</xref></sup> nerve regeneration,<sup><xref ref-type="bibr" rid="bibr21-0883911512467643">21</xref>,<xref ref-type="bibr" rid="bibr22-0883911512467643">22</xref></sup> bone regeneration<sup><xref ref-type="bibr" rid="bibr23-0883911512467643">23</xref>,<xref ref-type="bibr" rid="bibr24-0883911512467643">24</xref></sup> and vascular grafts.<sup><xref ref-type="bibr" rid="bibr22-0883911512467643">22</xref>,<xref ref-type="bibr" rid="bibr25-0883911512467643">25</xref>,<xref ref-type="bibr" rid="bibr26-0883911512467643">26</xref></sup></p>
<p>However, very few studies on the in vivo biocompatibility of BC have been published.<sup><xref ref-type="bibr" rid="bibr22-0883911512467643">22</xref>,<xref ref-type="bibr" rid="bibr27-0883911512467643">27</xref>
<xref ref-type="bibr" rid="bibr28-0883911512467643"/><xref ref-type="bibr" rid="bibr29-0883911512467643"/><xref ref-type="bibr" rid="bibr30-0883911512467643"/>–<xref ref-type="bibr" rid="bibr31-0883911512467643">31</xref></sup> Biocompatibility is a major requirement for any biomedical material. It can be defined as the ability to remain in contact with living tissue without causing intolerable toxic or allergic side effects while performing its function.<sup><xref ref-type="bibr" rid="bibr32-0883911512467643">32</xref></sup> In this context, BC has been modified to further enhance biocompatibility. The functionalization of BC using bioactive peptides was successfully developed in our research group for vascular replacements.<sup><xref ref-type="bibr" rid="bibr33-0883911512467643">33</xref></sup> The attachment of cells to biomedical materials can be improved by using adhesion molecules, such as fibronectin, vitronectin or laminin. These molecules, present in the extracellular matrix (ECM) of proteins, regulate the adhesion, migration and growth of cells by binding to integrin receptors located on the outer cellular membranes. The amino acid sequence, Arg-Gly-Asp (RGD), is known as the minimal essential cell adhesion peptide sequence present in these proteins. In the previous work, we described the production of recombinant proteins containing RGD sequences fused to a cellulose-binding module (CBM).<sup><xref ref-type="bibr" rid="bibr33-0883911512467643">33</xref></sup> The use of a CBM (a protein exhibiting high adsorption affinity and specificity for cellulose surfaces) fused with biologically active peptides provided a simple and effective approach to decorate the BC surface. This concept was further demonstrated using human microvascular endothelial cells (HMECs).<sup><xref ref-type="bibr" rid="bibr25-0883911512467643">25</xref></sup> The chimeric proteins were able to enhance endothelial cell adhesion to BC and stimulate angiogenesis.</p>
<p>In this study, we investigated the mechanical properties of BC tubes and the in vivo and in vitro biocompatibility of BC membranes for tissue-engineered blood vessels. The fate of long-term subcutaneous implants was analysed in sheep for 32 weeks. Once the recombinant protein contained bacterial CBM, the in vivo biocompatibility of native and RGD-CBM–treated BC membranes was analysed to determine whether the presence of the recombinant protein gave rise to any immunologic reaction. The implants were evaluated for chronic inflammation, foreign body responses, cell ingrowth and angiogenesis. The in vitro biocompatibility was evaluated using 3T3 mouse embryo fibroblast cultures, and the viability, morphology and cell ingrowth were analysed by the MTS [3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium] assay, fluorescence and cryo-scanning electron microscopy (CryoSEM).</p>
</sec>
<sec id="section2-0883911512467643" sec-type="materials|methods">
<title>Material and methods</title>
<sec id="section3-0883911512467643">
<title>Production of BC</title>
<p><italic>Gluconacetobacter xylinus</italic> (ATCC 53582) purchased from the American Type Culture Collection was grown in Hestrin–Schramm medium, pH 5.0. The medium was inoculated with the culture, added to the 24-well polystyrene plate (1 mL per well) and incubated statically at 30 °C for 5 days. The BC pellicles were purified by 2% sodium disulphide sulphonate (SDS) treatment at 60 °C, for 12 h, washed with distilled water until complete removal of SDS and then immersed in 4% NaOH at 60 °C for 90 min. After neutralization with distilled water, the samples were autoclaved and stored in phosphate-buffered solution (PBS), pH 7.4, at 4 °C, until use. The pellicle produced in a 24-well polystyrene plate presented a 15.5 mm diameter.</p>
<sec id="section4-0883911512467643">
<title>Preparation of tubular BC</title>
<p>The cultivation system used for the production of BC tubes (<xref ref-type="fig" rid="fig1-0883911512467643">Figure 1</xref>) was autoclaved and the Hestrin-Schramm medium was inoculated and added to the system. A layer of sterilized oil was placed surfacing the culture medium to reduce the growth of the bacteria at the air–liquid interface. The oxygen permeable silicon tube allowed the growth of the strictly aerobic bacteria next to the tube wall. To avoid the formation of air bubbles on the surface of the silicon tube – leading to irregularly shaped BC tubes – the system was first connected to an air supply for 4 days in an open circuit. After the formation of a thin BC pellicle, the air supply was disconnected and pure oxygen was injected at 0.5 bar for 14 days and allowed the production of a BC tube with 3 mm of inner diameter. The BC tubes were removed from the silicon mould and treated with a 4% NaOH solution, at 60 °C, for 12 h. The purified tube was then neutralized with filtered distilled water, autoclaved and stored in PBS, pH 7.4, at 4 °C, prior to use.</p>
<fig id="fig1-0883911512467643" position="float">
<label>Figure 1.</label>
<caption>
<p>Bacterial cellulose produced by <italic>Gluconacetobacter xylinus</italic> (ATCC 53582) grows around the silicon tube when an airflow is injected through the tube. (a) Scheme of the cultivation system and (b) bacterial cellulose tube.</p>
</caption>
<graphic xlink:href="10.1177_0883911512467643-fig1.tif"/></fig>
</sec></sec>
<sec id="section5-0883911512467643">
<title>Surface modification of BC with RGD-CBM protein</title>
<p>For surface modification of BC, the purified recombinant protein was added to the wells of 24-well polystyrene plates (0.25 mg of protein/well), coated with bacterial cellulose sheets produced in similar 24-well polystyrene plates as described in our previous work.<sup><xref ref-type="bibr" rid="bibr33-0883911512467643">33</xref></sup> The plates were incubated overnight at 4 °C. Unbound protein was removed, and the BC pellicles were washed with PBS and used in the in vitro and in vivo biocompatibility assays.</p>
</sec>
<sec id="section6-0883911512467643">
<title>Young’s modulus (E), TS and elongation-at-break (ϵ%)</title>
<p>TS, E and ϵ% were measured with an Instron Universal Testing Machine (Model 4500, Instron Corporation, Norwood, MA, USA). The initial grip separation was set at 15 mm, and the crosshead speed was set at 5 mm/min. TS was the stress needed to break a sample and calculated by dividing the maximum load (N) by the initial cross-sectional area (m<sup>2</sup>) of the specimen and is expressed in megapascals. E is the initial slop of the stress–strain curve and expressed in megapascals. ϵ% is the strain on a sample when it breaks. It was calculated as the ratio of the increased length to the initial length of a specimen (15 mm) and expressed as a percentage. BC tube was stretched lengthwise; 15 tubes were used in the test.</p>
</sec>
<sec id="section7-0883911512467643">
<title>Fibroblast adhesion and proliferation</title>
<p>The mitochondrial activity of the cultured cells was determined using a colorimetric assay, commonly used as a measure of cell viability. The MTS assay was performed as follows: the purified recombinant proteins were added to the wells of the 24-well polystyrene plates (0.25 mg of protein/well), coated with BC sheets. The BC sheets were produced in similar 24-well polystyrene plates, so as to fit tightly in the wells, completely covering the bottom surface. The fibroblasts 3T3 were seeded with 12 × 10<sup>4</sup> cells/well in Dulbecco’s modified Eagle’s medium (DMEM) without serum. Two hours after the addition of the cells, the wells were washed with PBS and DMEM with serum (10%) was added. The MTS assay of the attached and spreading 3T3 fibroblasts was carried out at 2 h, 72 h and 7 days, respectively, after the addition of the cells. The plates were incubated at 37 °C, in atmosphere of 5% CO<sub>2</sub> and 95% humidified air. The results were obtained from three different assays with triplicate samples.</p>
</sec>
<sec id="section8-0883911512467643">
<title>Morphological analysis by fluorescent microscopy</title>
<p>After 2 h, 72 h and 7 days after cell seeding on BC membranes untreated or treated with the RGD-CBM protein, the membranes were washed with pre-warmed PBS; the cells were then fixed in 4% formaldehyde (Pierce, Rockford, IL, USA) in PBS, permeabilized with acetone (Sigma-Aldrich, St. Louis, USA) at −20 °C and stained with Alexa Fluor 546-phalloidin (Molecular Probes, Eugene, OR, USA). Nuclei were visualized by staining with 4’,6-diamidino-2-phenylindole (DAPI). Microscopy observations were performed using an Olympus BX51 (Olympus Portugal SA, Porto, Portugal) fluorescence microscope.</p>
</sec>
<sec id="section9-0883911512467643">
<title>Cryo-scanning electron microscopy</title>
<p>After 14 days of cell seeding on BC – untreated or treated with the RGD-CBM protein – the membranes were washed with pre-warmed PBS; the cells were then fixed in 2.5% glutaraldehyde in PBS. Samples were washed in ultrapure water, and a piece of BC membrane was placed between two miniature rivets on a vacuum transfer rod and slam frozen in a nitrogen slush and transferred to the cryostat chamber, which was maintained at −150 °C. The top rivet was taken off to produce a fractured surface, the ice was sublimed at −90 °C during 2 min (for visualization of fibres on the dense side of BC) or 4 min (for visualization of fibres on the porous side of BC) and then the fractured surface was coated with gold/palladium. Afterwards, the sample was transferred to the microscope chamber, which was also maintained at −150 °C and examined at 15 kV using a working distance of 15 mm. The samples were analysed by use of a CryoSEM (Model Gatan ALTO 2500) at CEMUP (Centre for Materials Characterization from the University of Porto).</p>
<p>To visualize the BC tube fibres, samples were cut longitudinally and transversely. The transversal section was fractured and sublimed during 10 min; the longitudinal section was not fractured but sublimed for 30 min.</p>
</sec>
<sec id="section10-0883911512467643">
<title>In vivo biocompatibility studies</title>
<sec id="section11-0883911512467643">
<title>Experimental animals</title>
<p>Eighteen adult female white merino sheep (~60 kg each) were randomly divided in three groups of six animals each. Group number 1 was implanted with untreated BC discs, and group number 2 was implanted with BC discs (15.5 mm in diameter) and treated with recombinant protein (RGD-CBM). The control group, number 3, was implanted with expanded tetrafluoroethylene (MAXIFLO™ ePTFE Vascular Prosthesis, Vascutek Ltda, Scotland) disc samples with the same area as the BC implants.</p>
</sec>
<sec id="section12-0883911512467643">
<title>Surgical procedures</title>
<p>The animals were solids fasted for 48 h prior to the surgical procedure. An intravenous catheter of 20G was placed at the cephalic vein, and xylazine (0.2 mg/kg, intravenous) was given as a tranquilizer, followed by sodium thiopental, 15 mg/kg intravenous as the anaesthetic. The anaesthetic maintenance was isoflurane at 2% via endotracheal intubation carried by 100% oxygen with a 2 L/min flow.</p>
<p>For surgery, the sheep were placed in sternal recumbence over a tilted table so that the animal’s head and neck were always lower than the stomach to reduce risks of aspiration pneumonia. The wool was clipped in roughly square areas, and the skin was aseptic prepared with iodopovidone solution. The incisions were made over the dorsal area, starting over the last ribs and ending just cranially to the sacrum. These 3-cm-length incisions, three on the left side and two on the right one, were made parallel and 4 cm off the dorsal midline with 3 cm between incisions. After exposing the dorsal muscles, the BC/expanded polytetrafluoroethylene (ePTFE) disc samples were inserted under the skin distally to the midline. Subsequently, the skin was closed with a Supramid<sup>®</sup> USP1 suture and the ewes transferred to straw pens (4 m × 3 m) after surgery. The skin sutures were not removed in order to localize the implant site.</p>
</sec>
<sec id="section13-0883911512467643">
<title>Histological evaluations</title>
<p>The implants and the surrounding tissue were collected after a peripheral infiltration of 2% lidocaine, at 1, 2, 4, 8, 16 and 32 weeks post implantation. Two samples were collected from each animal, randomly selected from each group at specific temporal points. The samples were fixed in 10% formalin, paraffin embedded, cut in 2 µm and stained with haematoxylin and eosin (HE) for histological evaluation. The biological response parameters were assessed in the implant–tissue interface with three high power fields (×400) by at least two pathologists, for each sample and recorded in an appropriate formulary. All the biological response parameters were evaluated according to the ISO standard 10993-6 (annex E) which included the extent of fibrosis/fibrous capsule (layer in micrometres) and inflammation; the degeneration as determined by changes in tissue morphology; the number and distribution from the material–tissue interface of the inflammatory cell types, namely polymorphonuclear neutrophilic leucocytes (PMN), lymphocytes, plasma cells, eosinophils, macrophages and multinucleated cells; the presence, extent and type of necrosis; other tissue alterations such as vascularization, fatty infiltration and granuloma formation and the material parameters such as fragmentation and/or debris presence, form and location of remnants of degraded material. Based on the scoring system for the parameters, a total value was obtained for each animal in each group. The group value was subtracted by the control group value, and the test sample was recorded as follows:</p>
<p>Non-irritant (0.0 up to 2.9), slight irritant (3.0 up to 8.9), moderate irritant (9.0 up to 15.0) and severe irritant (&gt; 15) to the tissue as compared to the control sample irritant. Adverse histological responses were documented by photomicrography.</p>
<p>The collected data were submitted to statistical analyses. Analysis of variance followed by the Tukey multiple comparisons test was used to evaluate the statistical differences between the groups using the GraphPad Prism 5.0 software. Differences were considered statistically significant at <italic>P</italic> &lt; 0.05.</p>
<p>Measures were taken to minimize pain and discomfort taken in account for animal suffering and distress during the in vivo testing. All procedures were performed with the approval of the Veterinary Authorities of Portugal in accordance with the European Communities Council Directive of November 1986 (86/609/EEC).</p>
</sec></sec>
</sec>
<sec id="section14-0883911512467643" sec-type="results|discussion">
<title>Results and discussion</title>
<p>The production of the BC tubes was carried using different techniques as described in the literature.<sup><xref ref-type="bibr" rid="bibr22-0883911512467643">22</xref>,<xref ref-type="bibr" rid="bibr34-0883911512467643">34</xref></sup> Gatenholm and his group<sup><xref ref-type="bibr" rid="bibr26-0883911512467643">26</xref>,<xref ref-type="bibr" rid="bibr35-0883911512467643">35</xref>,<xref ref-type="bibr" rid="bibr36-0883911512467643">36</xref></sup> produced BC tubes by submerging silicone tubing in a test tube containing culture medium. The set-up used in this work for the production of BC tubes (<xref ref-type="fig" rid="fig1-0883911512467643">Figure 1</xref>) was similar to the one used by the Gatenholm group to produce BC tube with a smoother and denser luminal side and a more porous outer side (<xref ref-type="fig" rid="fig2-0883911512467643">Figure 2</xref>). According to Backdahl et al.,<sup><xref ref-type="bibr" rid="bibr26-0883911512467643">26</xref></sup> a smoother luminal surface, similar to the basal membrane of the luminal side of blood vessels, is preferable for the attachment of endothelial cells, while a porous outer side facilitated the integration with the host tissue better. The CryoSEM results also showed that, unlike the tubes produced by Putra et al.<sup><xref ref-type="bibr" rid="bibr34-0883911512467643">34</xref></sup>, no orientation of the fibrils network was observed.</p>
<fig id="fig2-0883911512467643" position="float">
<label>Figure 2.</label>
<caption>
<p>CryoSEM micrographs of bacterial cellulose tubes. Visualization through a longitudinal cut of (a) inner side and (b) outer side. Visualization through a transversal cut of (c) inner side and (d) outer side. Scale 60 μm (longitudinal images) and 10 μm (transversal images).</p>
</caption>
<graphic xlink:href="10.1177_0883911512467643-fig2.tif"/></fig>
<p>The lower Young’s modulus (E) values for the BC tubes were associated with minor vessel wall stiffness. The BC tubes produced in this work were more elastic lengthwise (lower E, 0.25 ± 0.07 MPa) than human arteries and veins and much lower than collagen and PTFE, two common polymers used as vascular grafts (<xref ref-type="table" rid="table1-0883911512467643">Table 1</xref>). Typical plots of wall stress versus strain in BC tube segments are shown in <xref ref-type="fig" rid="fig3-0883911512467643">Figure 3</xref> with an ϵ% of 31% ± 4.4%, a value higher than collagen (10%) but lower than PTFE (200–400). The TS from our BC tube was 0.19 ± 0.03 MPa, a value lower than the one obtained by Putra et al.<sup><xref ref-type="bibr" rid="bibr34-0883911512467643">34</xref></sup> (0.59 MPa). Although the values are in the same order of magnitude, the different properties may be assigned to variable thickness of the tubes. The TS values for the BC tubes (obtained in our lab and described by Putra et al.<sup><xref ref-type="bibr" rid="bibr34-0883911512467643">34</xref></sup>) are one order of magnitude lower than the ones reported for human arteries and veins (<xref ref-type="table" rid="table1-0883911512467643">Table 1</xref>). According to Sanchavanakit et al.,<sup><xref ref-type="bibr" rid="bibr37-0883911512467643">37</xref></sup> a BC dried film (from a 48-h culture) with a thickness of 0.12 mm presents a TS and break strain of 5.21 MPa and 3.75%, whereas for the re-swollen films, the values are 1.56 MPa and 8.0%, respectively. McKenna et al.<sup><xref ref-type="bibr" rid="bibr38-0883911512467643">38</xref></sup> reported a TS value of wet BC sheet grown between 48 and 96 h of 1.1–2.2 MPa, ϵ% of 16%–27% and E of 10–14 MPa. The BC production, as well as the mechanical properties, is influenced by the carbon and nitrogen sources and concentration, the pH and temperature, time of cultivation, the surface area of the fermentation system, the type of cultivation system (e.g. static or agitated cell culture) and differences in the bacterial strains. In addition, the treatment after synthesis influenced the properties of BC membranes.<sup><xref ref-type="bibr" rid="bibr8-0883911512467643">8</xref></sup></p>
<table-wrap id="table1-0883911512467643" position="float">
<label>Table 1.</label>
<caption>
<p>Comparison of the mechanical properties of BC tubes (3 mm of inner diameter and 1 mm of wall thickness) produced in this present work with BC tubes produced by Putra et al.,<sup><xref ref-type="bibr" rid="bibr34-0883911512467643">34</xref></sup> human arteries and veins and common polymers used as vascular grafts (collagen and PTFE)</p>
</caption>
<graphic alternate-form-of="table1-0883911512467643" xlink:href="10.1177_0883911512467643-table1.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th/>
<th align="left">Young’s modulus (MPa)</th>
<th align="left">Tensile strength (MPa)</th>
<th align="left">Elongation (%)</th>
<th align="left">References</th>
</tr>
</thead>
<tbody>
<tr>
<td>BC tube</td>
<td>0.25 ± 0.07</td>
<td>0.19 ± 0.03</td>
<td>31 ± 4.4</td>
<td><xref ref-type="table-fn" rid="table-fn1-0883911512467643">*</xref></td>
</tr>
<tr>
<td>BC tube</td>
<td>0.06</td>
<td>0.59</td>
<td>–</td>
<td>Putra et al.<sup><xref ref-type="bibr" rid="bibr34-0883911512467643">34</xref></sup></td>
</tr>
<tr>
<td>Arteries</td>
<td>1.54</td>
<td>1.57</td>
<td>–</td>
<td>Pukacki et al.<sup><xref ref-type="bibr" rid="bibr39-0883911512467643">39</xref></sup> and Purinya et al.<sup><xref ref-type="bibr" rid="bibr40-0883911512467643">40</xref></sup></td>
</tr>
<tr>
<td>Veins</td>
<td>3.11</td>
<td>2.65–3.3</td>
<td>–</td>
<td>Pukacki et al.<sup><xref ref-type="bibr" rid="bibr39-0883911512467643">39</xref></sup> and Purinya et al.<sup><xref ref-type="bibr" rid="bibr40-0883911512467643">40</xref></sup></td>
</tr>
<tr>
<td>Collagen</td>
<td>1000</td>
<td>50–100</td>
<td>10</td>
<td>Martins.<sup><xref ref-type="bibr" rid="bibr41-0883911512467643">41</xref></sup></td>
</tr>
<tr>
<td>PTFE</td>
<td>400</td>
<td>14–35</td>
<td>200–400</td>
<td>Martins.<sup><xref ref-type="bibr" rid="bibr41-0883911512467643">41</xref></sup></td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-0883911512467643"><p>‘*’: BC tubes produced in this work; ‘–’: not described.</p></fn>
<fn id="table-fn2-0883911512467643"><p>Values are presented as mean ± standard deviation.</p></fn>
</table-wrap-foot>
</table-wrap>
<fig id="fig3-0883911512467643" position="float">
<label>Figure 3.</label>
<caption>
<p>Tensile stress–strain curves of the lengthwise of BC tubes with an inner diameter and wall thickness of 3 and 1 mm, respectively.</p>
</caption>
<graphic xlink:href="10.1177_0883911512467643-fig3.tif"/></fig>
<p>The mechanical properties of the BC tubes produced using the method adopted in this work are inferior to the properties of both the commercial grafts available and the natural blood vessels. Therefore, a different method to provide thicker BC walls is required (ongoing work). Although BC is frequently referred to as exhibiting superior mechanical properties, its application as vascular grafts requires some improvement in this regard.</p>
<sec id="section15-0883911512467643">
<title>In vitro studies on the BC–cell interactions</title>
<p>In a static culture, <italic>G. xylinus</italic> builds up a cellulose network much denser on the culture medium–air interface than on the opposite side.<sup><xref ref-type="bibr" rid="bibr22-0883911512467643">22</xref>,<xref ref-type="bibr" rid="bibr26-0883911512467643">26</xref></sup> The MTS test (<xref ref-type="fig" rid="fig4-0883911512467643">Figure 4</xref>) indicated no significant differences in the fibroblast adhesion to the BC porous or dense side and also that the cells proliferated equally well on both sides, as previously reported in a study using human smooth muscle cells (SMC).<sup><xref ref-type="bibr" rid="bibr26-0883911512467643">26</xref></sup> The effect of the recombinant protein (RGD-CBM) on the adhesion of fibroblasts to BC was previously discussed.<sup><xref ref-type="bibr" rid="bibr33-0883911512467643">33</xref></sup> Fluorescence microscopy of the cell–BC interaction was more detailed in this work (<xref ref-type="fig" rid="fig5-0883911512467643">Figure 5</xref>), apart from increasing cell adhesion – as observed in MTS assays – the presence of RGD stimulated a uniform distribution of the cells which is important to the endothelialization of the graft, while cells coating the untreated BC seem to form aggregates (the images containing only labelled nuclei in <xref ref-type="fig" rid="fig5-0883911512467643">Figure 5</xref> allow a better visualization of this effect).</p>
<fig id="fig4-0883911512467643" position="float">
<label>Figure 4.</label>
<caption>
<p>MTS assays of fibroblast cultures at the dense or porous side of BC membrane. The MTS assay was developed at 2 h, 72 h and 7 days after cell seeding. Results are expressed as absorbance values at 490 nm.</p>
<p>BC: bacterial cellulose.</p>
</caption>
<graphic xlink:href="10.1177_0883911512467643-fig4.tif"/></fig>
<fig id="fig5-0883911512467643" position="float">
<label>Figure 5.</label>
<caption>
<p>Fluorescent microscopy images showing fibroblast cultured 7 days on BC pellicle. (a) Dense and (b) porous side of RGD-treated BC; (c) dense and (d) porous side of untreated BC. Nuclei were visualized by staining with DAPI (blue) and f-actin with Alexa Fluor 546-phalloidin (red). Actin and nuclei combined images were acquired using objectives 10× (scale 200 μm); nuclei images were acquired using objectives 20× (scale 100 μm).</p>
</caption>
<graphic xlink:href="10.1177_0883911512467643-fig5.tif"/></fig>
<p>The cells on the RGD-treated BC were more elongated than the cells covering the untreated pellicle on both sides as shown in <xref ref-type="fig" rid="fig6-0883911512467643">Figure 6</xref>. The more extended morphology, upon interaction with the adhesive peptides, seems to be driven by the greater number of focal contacts between integrins and RGD-containing peptides linked to the BC surface. It is known that a critical RGD density is essential for the establishment of mature and stable integrin adhesions, which, in turn, induce efficient cell migration, spreading and formation of focal adhesions.<sup><xref ref-type="bibr" rid="bibr42-0883911512467643">42</xref>
<xref ref-type="bibr" rid="bibr43-0883911512467643"/><xref ref-type="bibr" rid="bibr44-0883911512467643"/>–<xref ref-type="bibr" rid="bibr45-0883911512467643">45</xref></sup></p>
<fig id="fig6-0883911512467643" position="float">
<label>Figure 6.</label>
<caption>
<p>CryoSEM micrographs of bacterial cellulose cultured with fibroblasts after 14 days. (a) Dense and (b) porous side of RGD-treated BC; (c) dense and (d) porous side of untreated BC. Scale 10 μm.</p>
</caption>
<graphic xlink:href="10.1177_0883911512467643-fig6.tif"/></fig>
<p>The migration of cells is mediated by integrins, a diverse family of glycoproteins that form heterodimeric receptors for ECM molecules. During migration, cells project lamellipodia that attach to the ECM and simultaneously break existing ECM contacts at their trailing edge which allows the cell to pull itself forward.<sup><xref ref-type="bibr" rid="bibr46-0883911512467643">46</xref></sup> Animal cells cannot degrade cellulose<sup><xref ref-type="bibr" rid="bibr28-0883911512467643">28</xref></sup> and must push the nanofibrils aside while migrating into the cellulose network.<sup><xref ref-type="bibr" rid="bibr26-0883911512467643">26</xref></sup> The CryoSEM technique was also used for visualization of cell ingrowth in BC scaffold. The results showed that after 14 days of culture, the cells could not migrate through the BC fibres, once only cells on the surface were found. However, it has been demonstrated that cells may migrate through BC membranes. Andrade et al.<sup><xref ref-type="bibr" rid="bibr25-0883911512467643">25</xref></sup> and Backdahl et al.<sup><xref ref-type="bibr" rid="bibr26-0883911512467643">26</xref></sup> demonstrated the ingrowth of HMECs and SMC, respectively, through BC network using an invasion chamber where an attractant (serum, growth factor, etc.) is used to stimulate the cells to grow into the BC - in both cases, the cells were able to invade the fibrous cellulose matrix.</p>
</sec>
<sec id="section16-0883911512467643">
<title>In vivo biocompatibility studies</title>
<p>The effect of the recombinant protein containing a bacterial domain on the biocompatibility of BC implants was examined at 1, 2, 4, 8, 16 and 32 weeks post implantation for inflammatory reactions and degradation. The histology photographs of the BC membranes implanted subcutaneously in sheep and surrounding tissue reaction are shown in <xref ref-type="fig" rid="fig7-0883911512467643">Figure 7</xref>. Once there were no significant differences in biological responses by the host for untreated or RGD-CBM-treated BC, the images represent the results for both groups of the post-implantation times analysed.</p>
<fig id="fig7-0883911512467643" position="float">
<label>Figure 7.</label>
<caption>
<p>Histomorphology of bacterial cellulose membrane implanted subcutaneously in sheep and surrounding tissue reaction. Once there were no significant differences in biological responses by the host, the images represent the results for both groups of the post-implantation times analysed. (a) 1, (b) 2, (c) 4, (d) 8, (e) 16 and (f) 32 weeks post implantation. (a, b, c, d), (e) and (f), 40×, 100× and 400× magnification, respectively (haematoxylin and eosin staining). The solid arrows indicate the fibrous capsule formation. The dashed arrow on image (f) indicates small blood vessels formation. Asterisks (*) indicate bacterial cellulose.</p>
</caption>
<graphic xlink:href="10.1177_0883911512467643-fig7.tif"/></fig>
<p>At 1 week post implantation, there was a predominance of PMN and macrophage infiltrate at the implant–tissue junction in both experimental groups 1 and 2 and in the control group (ePTFE), suggesting an acute/subacute inflammatory reaction (<xref ref-type="fig" rid="fig7-0883911512467643">Figure 7(a)</xref>). In the second week post implantation, an increase in macrophages, plasma cells and lymphocytes infiltration associated to a proliferation of local small blood vessels was compatible with a chronic inflammation. The persistence of the inflammatory stimuli in the BC and control group led to a change from acute to chronic inflammation.<sup><xref ref-type="bibr" rid="bibr47-0883911512467643">47</xref></sup> This chronic inflammation response was confined to the implantation site (<xref ref-type="fig" rid="fig7-0883911512467643">Figure 7(b)</xref>).</p>
<p>During the initial 4 weeks of observation, lymphocytes and macrophages were the most prominent cells in all three groups. The type of cell infiltrate and the increased neovascularisation, surrounding the implant area, were compatible with a chronic inflammation (<xref ref-type="fig" rid="fig7-0883911512467643">Figure 7(c)</xref>). At 4 weeks post implantation, a more intense inflammation in the experimental group 1 was observed (<xref ref-type="fig" rid="fig8-0883911512467643">Figure 8</xref>). The macrophages are probably the most important cell type in chronic inflammation because of the great number of biologically active products expressed by these cells.<sup><xref ref-type="bibr" rid="bibr48-0883911512467643">48</xref></sup> Among these, the growth factors were responsible for the growth of fibroblasts and blood vessels observed in all groups at 4 weeks post implantation.</p>
<fig id="fig8-0883911512467643" position="float">
<label>Figure 8.</label>
<caption>
<p>Inflammation degree of untreated BC (group 1), BC treated with RGD-CBM protein (group 2) and control (ePTFE) implants at 1, 2, 4, 8, 16 and 32 weeks post implantation. Significant differences (<italic>P</italic> &lt; 0.05) are indicated with an asterisk (*).</p>
<p>ePTFE: expanded polytetrafluoroethylene.</p>
</caption>
<graphic xlink:href="10.1177_0883911512467643-fig8.tif"/></fig>
<p>After 8 weeks post implantation, a marked decrease in inflammation was detected in both experimental and control groups (<xref ref-type="fig" rid="fig7-0883911512467643">Figures 7(d)</xref> and <xref ref-type="fig" rid="fig8-0883911512467643">8</xref>). These findings can be related to the formation of granulation tissue, the hallmark of healing inflammation, consisting in the proliferation of fibroblasts, macrophages and vascular endothelial cells, and a decrease in inflammatory cells such as PMN and lymphocytes.</p>
<p>The foreign body reaction (FBR), mainly by macrophages, and/or foreign body giant cells at the tissue–implant interface and associated with the fibrous encapsulation were observed at 16 and 32 weeks of the experimental process (<xref ref-type="fig" rid="fig7-0883911512467643">Figure 7(e)</xref> and <xref ref-type="fig" rid="fig7-0883911512467643">(f)</xref>). With biocompatible materials, the composition of the FBR in the implant site may be controlled by the surface properties of the biomaterial, the form of the implant and the relationship between the surface area of the biomaterial and the volume of the implant.<sup><xref ref-type="bibr" rid="bibr49-0883911512467643">49</xref>,<xref ref-type="bibr" rid="bibr50-0883911512467643">50</xref></sup> High surface-to-volume implants, such as the BC membranes, will have higher counts of macrophages and foreign body giant cells in the tissue–implant surface than that in case of smooth–surface implants.<xref ref-type="bibr" rid="bibr51-0883911512467643">51</xref> Our results also showed that, although there is a tendency in the formation of a more intense fibrosis in ePTFE implants there were no significant differences between the three groups tested at 16 and 32 weeks (<xref ref-type="table" rid="table2-0883911512467643">Table 2</xref>). The neovascularisation was similar to both BC groups and the ePTFE group, especially in the longer periods of implantation (<xref ref-type="table" rid="table2-0883911512467643">Table 2</xref>).</p>
<table-wrap id="table2-0883911512467643" position="float">
<label>Table 2.</label>
<caption>
<p>Scores attributed to the level of giant cells<sup><xref ref-type="table-fn" rid="table-fn3-0883911512467643">1</xref></sup>, fibrosis<sup><xref ref-type="table-fn" rid="table-fn4-0883911512467643">2</xref></sup> and neovascularisation<sup><xref ref-type="table-fn" rid="table-fn3-0883911512467643">3</xref></sup> at 1, 2, 4, 8, 16 and 32 weeks after implantation</p>
</caption>
<graphic alternate-form-of="table2-0883911512467643" xlink:href="10.1177_0883911512467643-table2.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th align="left">Event</th>
<th align="left" colspan="6">Weeks<hr/></th>
</tr>
<tr>
<th/>
<th align="left">1</th>
<th align="left">2</th>
<th align="left">4</th>
<th align="left">8</th>
<th align="left">16</th>
<th align="left">32</th>
</tr>
</thead>
<tbody>
<tr>
<td>Giant cells</td>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
</tr>
<tr>
<td>ePTFE</td>
<td>0<sup><xref ref-type="table-fn" rid="table-fn5-0883911512467643">4</xref></sup> (0/0)<sup><xref ref-type="table-fn" rid="table-fn7-0883911512467643">5a</xref></sup></td>
<td>0.8 (0/2)<sup><xref ref-type="table-fn" rid="table-fn7-0883911512467643">a</xref></sup></td>
<td>0.4 (0/1)<sup><xref ref-type="table-fn" rid="table-fn7-0883911512467643">a</xref></sup></td>
<td>0 (0/0)<sup><xref ref-type="table-fn" rid="table-fn7-0883911512467643">a</xref></sup></td>
<td>0 (0/0)<sup><xref ref-type="table-fn" rid="table-fn7-0883911512467643">a</xref></sup></td>
<td>1 (0/2)<sup><xref ref-type="table-fn" rid="table-fn7-0883911512467643">a</xref></sup></td>
</tr>
<tr>
<td>Group 1</td>
<td>0 (0/0)<sup><xref ref-type="table-fn" rid="table-fn7-0883911512467643">a</xref></sup></td>
<td>1 (1/1)<sup><xref ref-type="table-fn" rid="table-fn7-0883911512467643">a</xref></sup></td>
<td>1.5 (1/2)<sup><xref ref-type="table-fn" rid="table-fn7-0883911512467643">a</xref></sup></td>
<td>0 (0/0)<sup><xref ref-type="table-fn" rid="table-fn7-0883911512467643">a</xref></sup></td>
<td>0 (0/0)<sup><xref ref-type="table-fn" rid="table-fn7-0883911512467643">a</xref></sup></td>
<td>2 (2/2)<sup><xref ref-type="table-fn" rid="table-fn7-0883911512467643">a</xref></sup></td>
</tr>
<tr>
<td>Group 2</td>
<td>0 (0/0)<sup><xref ref-type="table-fn" rid="table-fn7-0883911512467643">a</xref></sup></td>
<td>1.75 (1/3)<sup><xref ref-type="table-fn" rid="table-fn7-0883911512467643">a</xref></sup></td>
<td>0.5 (0/1)<sup><xref ref-type="table-fn" rid="table-fn7-0883911512467643">a</xref></sup></td>
<td>0 (0/0)<sup><xref ref-type="table-fn" rid="table-fn7-0883911512467643">a</xref></sup></td>
<td>1 (1/1)<sup><xref ref-type="table-fn" rid="table-fn7-0883911512467643">b</xref></sup></td>
<td>1 (1/1)<sup><xref ref-type="table-fn" rid="table-fn7-0883911512467643">a</xref></sup></td>
</tr>
<tr>
<td>Fibrosis</td>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
</tr>
<tr>
<td>ePTFE</td>
<td>1.8 (1/2)<sup><xref ref-type="table-fn" rid="table-fn7-0883911512467643">a</xref></sup></td>
<td>3.2 (2/4)<sup><xref ref-type="table-fn" rid="table-fn7-0883911512467643">a</xref></sup></td>
<td>1.8 (1/2)<sup><xref ref-type="table-fn" rid="table-fn7-0883911512467643">ab</xref></sup></td>
<td>1 (1/1)<sup><xref ref-type="table-fn" rid="table-fn7-0883911512467643">a</xref></sup></td>
<td>1.2 (1/2)<sup><xref ref-type="table-fn" rid="table-fn7-0883911512467643">a</xref></sup></td>
<td>2.4 (1/4)<sup><xref ref-type="table-fn" rid="table-fn7-0883911512467643">a</xref></sup></td>
</tr>
<tr>
<td>Group 1</td>
<td>1.5 (1/2)<sup><xref ref-type="table-fn" rid="table-fn7-0883911512467643">a</xref></sup></td>
<td>1.25 (1/2)<sup><xref ref-type="table-fn" rid="table-fn7-0883911512467643">b</xref></sup></td>
<td>1 (1/1)<sup><xref ref-type="table-fn" rid="table-fn7-0883911512467643">a</xref></sup></td>
<td>0 (0/0)<sup><xref ref-type="table-fn" rid="table-fn7-0883911512467643">b</xref></sup></td>
<td>1 (1/1)<sup><xref ref-type="table-fn" rid="table-fn7-0883911512467643">a</xref></sup></td>
<td>1 (1/1)<sup><xref ref-type="table-fn" rid="table-fn7-0883911512467643">a</xref></sup></td>
</tr>
<tr>
<td>Group 2</td>
<td>1.5 (1/2)<sup><xref ref-type="table-fn" rid="table-fn7-0883911512467643">a</xref></sup></td>
<td>1 (1/1)<sup><xref ref-type="table-fn" rid="table-fn7-0883911512467643">b</xref></sup></td>
<td>2.5 (2/3)<sup><xref ref-type="table-fn" rid="table-fn7-0883911512467643">b</xref></sup></td>
<td>0 (0/0)<sup><xref ref-type="table-fn" rid="table-fn7-0883911512467643">b</xref></sup></td>
<td>1 (1/1)<sup><xref ref-type="table-fn" rid="table-fn7-0883911512467643">a</xref></sup></td>
<td>1 (1/1)<sup><xref ref-type="table-fn" rid="table-fn7-0883911512467643">a</xref></sup></td>
</tr>
<tr>
<td>Neovascularisation</td>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
</tr>
<tr>
<td>ePTFE</td>
<td>2.4 (1/4)<sup><xref ref-type="table-fn" rid="table-fn7-0883911512467643">a</xref></sup></td>
<td>3.2 (3/4)<sup><xref ref-type="table-fn" rid="table-fn7-0883911512467643">a</xref></sup></td>
<td>2.4 (2/3)<sup><xref ref-type="table-fn" rid="table-fn7-0883911512467643">a</xref></sup></td>
<td>2.8 (2/3)<sup><xref ref-type="table-fn" rid="table-fn7-0883911512467643">a</xref></sup></td>
<td>3 (3/3)<sup><xref ref-type="table-fn" rid="table-fn7-0883911512467643">a</xref></sup></td>
<td>3 (2/4)<sup><xref ref-type="table-fn" rid="table-fn7-0883911512467643">a</xref></sup></td>
</tr>
<tr>
<td>Group 1</td>
<td>3 (2/4)<sup><xref ref-type="table-fn" rid="table-fn7-0883911512467643">a</xref></sup></td>
<td>2.5 (2/3)<sup>ab</sup></td>
<td>4 (4/4)<sup><xref ref-type="table-fn" rid="table-fn7-0883911512467643">b</xref></sup></td>
<td>1 (1/1)<sup><xref ref-type="table-fn" rid="table-fn7-0883911512467643">b</xref></sup></td>
<td>2 (1/3)<sup><xref ref-type="table-fn" rid="table-fn7-0883911512467643">a</xref></sup></td>
<td>2 (2/2)<sup><xref ref-type="table-fn" rid="table-fn7-0883911512467643">a</xref></sup></td>
</tr>
<tr>
<td>Group 2</td>
<td>2.5 (2/3)<sup><xref ref-type="table-fn" rid="table-fn7-0883911512467643">a</xref></sup></td>
<td>1.5 (1/2)<sup><xref ref-type="table-fn" rid="table-fn7-0883911512467643">b</xref></sup></td>
<td>2 (2/2)<sup><xref ref-type="table-fn" rid="table-fn7-0883911512467643">a</xref></sup></td>
<td>1 (1/1)<sup><xref ref-type="table-fn" rid="table-fn7-0883911512467643">b</xref></sup></td>
<td>2.5 (1/4)<sup><xref ref-type="table-fn" rid="table-fn7-0883911512467643">a</xref></sup></td>
<td>1.5 (1/2)<sup><xref ref-type="table-fn" rid="table-fn7-0883911512467643">a</xref></sup></td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn3-0883911512467643">
<label>1,3</label>
<p>Score: absent (0), rare (1), mild (2), moderate (3), severe (4).</p></fn>
<fn id="table-fn4-0883911512467643">
<label>2</label>
<p>Score: absent (0), narrow band (1), moderately thick band (2), thick band (3), extensive band (4).</p></fn>
<fn id="table-fn5-0883911512467643">
<label>4</label>
<p>Mean score of analysis.</p></fn>
<fn id="table-fn6-0883911512467643">
<label>5</label>
<p>The number inside parenthesis represents the minimal and the maximal score observed in the event.</p></fn>
<fn id="table-fn7-0883911512467643"><p>For each event, values followed by different letters (a or b) on columns were significantly different (<italic>P</italic> &lt; 0.05).</p></fn>
</table-wrap-foot>
</table-wrap>
<p>Multinucleated giant cells in the vicinity of a foreign body are generally considered evidence of a more severe FBR; however, it is not uncommon to see very large foreign body giant cells containing large numbers of nuclei on the surface of biomaterials.<sup><xref ref-type="bibr" rid="bibr52-0883911512467643">52</xref>,<xref ref-type="bibr" rid="bibr53-0883911512467643">53</xref></sup> Significant differences of inflammation degree between the two BC groups were observed only at 1 and 4 weeks (<xref ref-type="fig" rid="fig8-0883911512467643">Figure 8</xref>). However, at 8, 16 and 32 weeks, no differences were observed. Although the adhesion peptide (RGD) present on BC membranes (group 2) could potentially interact with monocytes/macrophages (these cells express α<sub>V</sub>β<sub>3</sub> integrin),<sup><xref ref-type="bibr" rid="bibr53-0883911512467643">53</xref></sup> influencing the adhesion and chemotaxis of these cells, a more intense infiltration of inflammatory cells was not observed.</p>
<p>In this study, BC and BC treated with the recombinant protein presented an irritant ranking of 5.5 and 3.0, respectively; thus both groups were slightly irritating to the tissue compared to the negative control sample (ePTFE).</p>
<p>In the study by Märtson et al.,<sup><xref ref-type="bibr" rid="bibr54-0883911512467643">54</xref></sup> a mild FBR was observed at 16 weeks post implantation by an implanted cellulose sponge (Cellspon<sup>®</sup>) in the subcutaneous tissue of rats from 1 to 60 weeks. This is in agreement with the observation made in the present study. At the latter stages of the current assay (16 and 32 weeks), a change in the shape of the membrane was observed, which may be assigned to similar events, but our data do not allow an objective position regarding the possible degradation of the BC implants.</p>
<p>Only a few studies have addressed the in vivo biocompatibility of BC, however most were with small animals and over a short period of time.<sup><xref ref-type="bibr" rid="bibr20-0883911512467643">20</xref>,<xref ref-type="bibr" rid="bibr27-0883911512467643">27</xref>
<xref ref-type="bibr" rid="bibr28-0883911512467643"/>–<xref ref-type="bibr" rid="bibr29-0883911512467643">29</xref></sup> Consequently, the different results obtained until now with BC implants may be explained by the different animal species used as well as the different methodologies used in assessing the inflammatory reaction. Overall, from the present work, a classification of BC as a biocompatible material may be drawn. However, acceptable tissue compatibility in one implantation site may not be favourable in another site. Thus, to employ BC as a biomedical scaffold for artificial blood vessels requires additional compatibility studies, in which the BC is subjected to the environment that exists in the grafting site in the vasculature.</p>
</sec></sec>
<sec id="section17-0883911512467643" sec-type="conclusions">
<title>Conclusion</title>
<p>It was found that BC triggers a biological reaction typical of high surface-to-volume implants with an acute/subacute inflammatory reaction after 1 week post implantation that advanced to a mild chronic inflammation that was confined to the implantation site and associated with neovascularisation. The presence of giant cells was observed at latter time periods as well as narrow fibrous capsule surrounding the implant. There were no significant differences in the degree of inflammation between the BC coated with the recombinant protein RGD-CBM and the native BC. The BC implants were considered slightly more irritating to the tissue compared to the negative control sample (ePTFE). Based on CryoSEM analysis, the BC tubes have a denser luminal side and a porous outer side and non-oriented fibril network. In addition to increasing cell adhesion, the presence of RGD stimulated cellular elongation with an even cell distribution, while cells on untreated BC were round and tended to form aggregates. Mechanically, the small-diameter BC tubes had elasticity higher than human arteries and veins. Thus, BC could be used as a biomedical scaffold for artificial blood vessels but requires additional compatibility studies.</p>
</sec>
</body>
<back>
<ack><p>Fábia K. Andrade is the recipient of a fellowship from Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES, Brazil). Fábia K Andrade and Nuno Alexandre contributed equally to this work.</p></ack>
<fn-group>
<fn fn-type="financial-disclosure">
<label>Funding</label>
<p>This work is funded by FEDER Funds through the Operational Programme for Competitiveness Factors – COMPETE and National Funds through FCT – Foundation for Science and Technology under the Strategic Project PEst-C/AGR/UI0115/2011, the project PTDC/EBB-EBI/112170/2009 and under the PhD grant reference SFRH/BD/64838/2009. This work was also supported by Fundação para a Ciência e Tecnologia (FCT), Ministério da Educação e da Ciência, Portugal, through the research Project PTDC/DES/104036/2008 and by QREN No. 1372 para Criação de um Núcleo I&amp;DT para Desenvolvimento de Produtos nas Áreas de Medicina Regenerativa e de Terapias Celulares – Núcleo Biomat &amp; Cell.</p></fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-0883911512467643">
<label>1.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Langer</surname><given-names>R</given-names></name>
<name><surname>Vacanti</surname><given-names>JP</given-names></name>
</person-group>. <article-title>Tissue engineering</article-title>. <source>Science</source> <year>1993</year>; <volume>260</volume>: <fpage>920</fpage>–<lpage>926</lpage>.</citation>
</ref>
<ref id="bibr2-0883911512467643">
<label>2.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Campbell</surname><given-names>JH</given-names></name>
<name><surname>Efendy</surname><given-names>JL</given-names></name>
<name><surname>Campbell</surname><given-names>GR</given-names></name>
</person-group>. <article-title>Novel vascular graft grown within recipient’s own peritoneal cavity</article-title>. <source>Circ Res</source> <year>1999</year>; <volume>85</volume>: <fpage>1173</fpage>–<lpage>1178</lpage>.</citation>
</ref>
<ref id="bibr3-0883911512467643">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Chue</surname><given-names>WL</given-names></name>
<name><surname>Campbell</surname><given-names>GR</given-names></name>
<name><surname>Caplice</surname><given-names>N</given-names></name>
<etal/></person-group>. <article-title>Dog peritoneal and pleural cavities as bioreactors to grow autologous vascular grafts</article-title>. <source>J Vasc Surg</source> <year>2004</year>; <volume>39</volume>: <fpage>859</fpage>–<lpage>867</lpage>.</citation>
</ref>
<ref id="bibr4-0883911512467643">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Konig</surname><given-names>G</given-names></name>
<name><surname>McAllister</surname><given-names>TN</given-names></name>
<name><surname>Dusserre</surname><given-names>N</given-names></name>
<etal/></person-group>. <article-title>Mechanical properties of completely autologous human tissue engineered blood vessels compared to human saphenous vein and mammary artery</article-title>. <source>Biomaterials</source> <year>2009</year>; <volume>30</volume>: <fpage>1542</fpage>–<lpage>1550</lpage>.</citation>
</ref>
<ref id="bibr5-0883911512467643">
<label>5.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>L’Heureux</surname><given-names>N</given-names></name>
<name><surname>Dusserre</surname><given-names>N</given-names></name>
<name><surname>Konig</surname><given-names>G</given-names></name>
<etal/></person-group>. <article-title>Human tissue-engineered blood vessels for adult arterial revascularization</article-title>. <source>Nat Med</source> <year>2006</year>; <volume>12</volume>: <fpage>361</fpage>–<lpage>365</lpage>.</citation>
</ref>
<ref id="bibr6-0883911512467643">
<label>6.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>L’Heureux</surname><given-names>N</given-names></name>
<name><surname>Germain</surname><given-names>L</given-names></name>
<name><surname>Labbe</surname><given-names>R</given-names></name>
<etal/></person-group>. <article-title>In vitro construction of a human blood vessel from cultured vascular cells: a morphologic study</article-title>. <source>J Vasc Surg</source> <year>1993</year>; <volume>17</volume>: <fpage>499</fpage>–<lpage>509</lpage>.</citation>
</ref>
<ref id="bibr7-0883911512467643">
<label>7.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>L’Heureux</surname><given-names>N</given-names></name>
<name><surname>Paquet</surname><given-names>S</given-names></name>
<name><surname>Labbe</surname><given-names>R</given-names></name>
<etal/></person-group>. <article-title>A completely biological tissue-engineered human blood vessel</article-title>. <source>FASEB J</source> <year>1998</year>; <volume>12</volume>: <fpage>47</fpage>–<lpage>56</lpage>.</citation>
</ref>
<ref id="bibr8-0883911512467643">
<label>8.</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Andrade</surname><given-names>FK</given-names></name>
<name><surname>Pertile</surname><given-names>RAN</given-names></name>
<name><surname>Douradoa</surname><given-names>F</given-names></name>
<etal/></person-group>. <article-title>Bacterial cellulose: properties, production and applications</article-title>. In: <person-group person-group-type="editor">
<name><surname>Lejeune</surname><given-names>A and</given-names></name>
<name><surname>Deprez</surname><given-names>T</given-names></name>
</person-group>. (eds) <source>Cellulose: structure and properties, derivatives and industrial uses</source>. <publisher-name>Nova Science Publishers, Inc.</publisher-name>, <year>2010</year> <publisher-loc>Hauppauge, NY, USA</publisher-loc>, pp.<fpage>427</fpage>–<lpage>458</lpage>.</citation>
</ref>
<ref id="bibr9-0883911512467643">
<label>9.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Oliveira</surname><given-names>RCB</given-names></name>
<name><surname>Souza</surname><given-names>FC</given-names></name>
<name><surname>Castro</surname><given-names>M</given-names></name>
</person-group>. <article-title>Avaliação da resposta tecidual quando da substituição da cartilagem do septo nasal de coelhos por manta de celulose bacteriana. Estudo experimental</article-title>. <source>ACTA ORL/Técnicas em Otorrinolaringologia</source> <year>2007</year>; <volume>25</volume>: <fpage>267</fpage>–<lpage>277</lpage>.</citation>
</ref>
<ref id="bibr10-0883911512467643">
<label>10.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Svensson</surname><given-names>A</given-names></name>
<name><surname>Nicklasson</surname><given-names>E</given-names></name>
<name><surname>Harrah</surname><given-names>T</given-names></name>
<etal/></person-group>. <article-title>Bacterial cellulose as a potential scaffold for tissue engineering of cartilage</article-title>. <source>Biomaterials</source> <year>2005</year>; <volume>26</volume>: <fpage>419</fpage>–<lpage>431</lpage>.</citation>
</ref>
<ref id="bibr11-0883911512467643">
<label>11.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Fontana</surname><given-names>JD</given-names></name>
<name><surname>De Souza</surname><given-names>AM</given-names></name>
<name><surname>Fontana</surname><given-names>CK</given-names></name>
<etal/></person-group>. <article-title>Acetobacter cellulose pellicle as a temporary skin substitute</article-title>. <source>Appl Biochem Biotechnol</source> <year>1990</year>; <volume>24–25</volume>: <fpage>253</fpage>–<lpage>264</lpage>.</citation>
</ref>
<ref id="bibr12-0883911512467643">
<label>12.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Pippi</surname><given-names>NL</given-names></name>
<name><surname>Sampaio</surname><given-names>AJSA</given-names></name>
</person-group>. <article-title>Estudos preliminares sobre o comportamento do Biofill na ceratoplastia lamelar em coelhos</article-title>. <source>Cienc Rural</source> <year>1990</year>; <volume>20</volume>: <fpage>297</fpage>–<lpage>302</lpage>.</citation>
</ref>
<ref id="bibr13-0883911512467643">
<label>13.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lin</surname><given-names>Y</given-names></name>
<name><surname>Chen</surname><given-names>K</given-names></name>
<name><surname>Ou</surname><given-names>K</given-names></name>
<etal/></person-group>. <article-title>Effects of different extracellular matrices and growth factor immobilization on biodegradability and biocompatibility of macroporous bacterial cellulose</article-title>. <source>J Bioact Compat Polym</source> <year>2011</year>; <volume>6</volume>: <fpage>508</fpage>–<lpage>518</lpage>.</citation>
</ref>
<ref id="bibr14-0883911512467643">
<label>14.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>dos Anjos</surname><given-names>B</given-names></name>
<name><surname>Novaes</surname><given-names>AB</given-names></name>
<name><surname>Meffert</surname><given-names>R</given-names></name>
<etal/></person-group>. <article-title>Clinical comparison of cellulose and expanded polytetrafluoroethylene membranes in the treatment of class II furcations in mandibular molars with 6-month re-entry</article-title>. <source>J Periodontol</source> <year>1998</year>; <volume>69</volume>: <fpage>454</fpage>–<lpage>459</lpage>.</citation>
</ref>
<ref id="bibr15-0883911512467643">
<label>15.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Novaes</surname><given-names>AB</given-names></name>
<name><surname>Novaes</surname><given-names>AB</given-names></name>
</person-group>. <article-title>Bone formation over a TiAl6V4 (IMZ) implant placed into an extraction socket in association with membrane therapy (Gengiflex)</article-title>. <source>Clin Oral Implants Res</source> <year>1993</year>; <volume>4</volume>: <fpage>106</fpage>–<lpage>110</lpage>.</citation>
</ref>
<ref id="bibr16-0883911512467643">
<label>16.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Novaes</surname><given-names>AB</given-names></name>
<name><surname>Novaes</surname><given-names>AB</given-names></name>
</person-group>. <article-title>Immediate implants placed into infected sites: a clinical report</article-title>. <source>Int J Oral Maxillofac Implants</source> <year>1995</year>; <volume>10</volume>: <fpage>609</fpage>–<lpage>613</lpage>.</citation>
</ref>
<ref id="bibr17-0883911512467643">
<label>17.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Novaes</surname><given-names>AB</given-names></name>
<name><surname>Novaes</surname><given-names>AB</given-names></name>
</person-group>. <article-title>Soft tissue management for primary closure in guided bone regeneration: surgical technique and case report</article-title>. <source>Int J Oral Maxillofac Implants</source> <year>1997</year>; <volume>12</volume>: <fpage>84</fpage>–<lpage>87</lpage>.</citation>
</ref>
<ref id="bibr18-0883911512467643">
<label>18.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Novaes</surname><given-names>AB</given-names></name>
<name><surname>Novaes</surname><given-names>AB</given-names></name>
<name><surname>Grissi</surname><given-names>MFM</given-names></name>
<etal/></person-group>. <article-title>Gengiflex, an alkali-cellulose membrane for GTR: histologic observations</article-title>. <source>Braz Dent J</source> <year>1993</year>; <volume>4</volume>: <fpage>65</fpage>–<lpage>71</lpage>.</citation>
</ref>
<ref id="bibr19-0883911512467643">
<label>19.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Salata</surname><given-names>LA</given-names></name>
<name><surname>Craig</surname><given-names>GT</given-names></name>
<name><surname>Brook</surname><given-names>IM</given-names></name>
</person-group>. <article-title>In-vivo evaluation of a new membrane (Gengiflex) for guided bone regeneration. Divisional abstracts: The British society of Dental Research</article-title>. <source>J Dent Res 1995</source>; <volume>74</volume>: <fpage>825</fpage>.</citation>
</ref>
<ref id="bibr20-0883911512467643">
<label>20.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sonohara</surname><given-names>MK</given-names></name>
<name><surname>Greghi</surname><given-names>SLA</given-names></name>
</person-group>. <article-title>Avaliação da resposta biológica a diferentes barreiras mecânicas, utilizadas na técnica de regeneração tecidual guiada (RTG)</article-title>. <source>J Appl Oral Sci</source> <year>1994</year>; <volume>2</volume>: <fpage>96</fpage>–<lpage>102</lpage>.</citation>
</ref>
<ref id="bibr21-0883911512467643">
<label>21.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Brancher</surname><given-names>JA</given-names></name>
<name><surname>Torres</surname><given-names>MF</given-names></name>
</person-group>. <article-title>Reparação microcirúrgica de nervo facial de ratos Wistar por meio de sutura – Parte II</article-title>. <source>Rev Sul-Bras Odontol</source> <year>2005</year>; <volume>2</volume>: <fpage>34</fpage>–<lpage>38</lpage>.</citation>
</ref>
<ref id="bibr22-0883911512467643">
<label>22.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Klemm</surname><given-names>D</given-names></name>
<name><surname>Schumann</surname><given-names>D</given-names></name>
<name><surname>Udhardt</surname><given-names>U</given-names></name>
<etal/></person-group>. <article-title>Bacterial synthesized cellulose – artificial blood vessels for microsurgery</article-title>. <source>Prog Polym Sci</source> <year>2001</year>; <volume>26</volume>: <fpage>1561</fpage>–<lpage>1603</lpage>.</citation>
</ref>
<ref id="bibr23-0883911512467643">
<label>23.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Chen</surname><given-names>YM</given-names></name>
<name><surname>Xi</surname><given-names>T</given-names></name>
<name><surname>Zheng</surname><given-names>Y</given-names></name>
<etal/></person-group>. <article-title>In vitro cytotoxicity of bacterial cellulose scaffolds used for tissue-engineered bone</article-title>. <source>J Bioact Compat Polym</source> <year>2009</year>; <volume>24</volume>: <fpage>137</fpage>–<lpage>145</lpage>.</citation>
</ref>
<ref id="bibr24-0883911512467643">
<label>24.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Zaborowska</surname><given-names>M</given-names></name>
<name><surname>Bodin</surname><given-names>A</given-names></name>
<name><surname>Bäckdahl</surname><given-names>H</given-names></name>
<etal/></person-group>. <article-title>Microporous bacterial cellulose as a potential scaffold for bone regeneration</article-title>. <source>Acta Biomater</source> <year>2010</year>; <volume>6</volume>: <fpage>2540</fpage>–<lpage>2547</lpage>.</citation>
</ref>
<ref id="bibr25-0883911512467643">
<label>25.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Andrade</surname><given-names>FK</given-names></name>
<name><surname>Costa</surname><given-names>R</given-names></name>
<name><surname>Domingues</surname><given-names>L</given-names></name>
<etal/></person-group>. <article-title>Improving bacterial cellulose for blood vessel replacement: functionalization with a chimeric protein containing a cellulose-binding module and an adhesion peptide</article-title>. <source>Acta Biomater</source> <year>2010</year>; <volume>6</volume>: <fpage>4034</fpage>–<lpage>4041</lpage>.</citation>
</ref>
<ref id="bibr26-0883911512467643">
<label>26.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Backdahl</surname><given-names>H</given-names></name>
<name><surname>Helenius</surname><given-names>G</given-names></name>
<name><surname>Bodin</surname><given-names>A</given-names></name>
<etal/></person-group>. <article-title>Mechanical properties of bacterial cellulose and interactions with smooth muscle cells</article-title>. <source>Biomaterials</source> <year>2006</year>; <volume>27</volume>: <fpage>2141</fpage>–<lpage>2149</lpage>.</citation>
</ref>
<ref id="bibr27-0883911512467643">
<label>27.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Esguerra</surname><given-names>M</given-names></name>
<name><surname>Fink</surname><given-names>H</given-names></name>
<name><surname>Laschke</surname><given-names>MW</given-names></name>
<etal/></person-group>. <article-title>Intravital fluorescent microscopic evaluation of bacterial cellulose as scaffold for vascular grafts</article-title>. <source>J Biomed Mater Res A</source> <year>2010</year>; <volume>93</volume>: <fpage>140</fpage>–<lpage>149</lpage>.</citation>
</ref>
<ref id="bibr28-0883911512467643">
<label>28.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Helenius</surname><given-names>G</given-names></name>
<name><surname>Backdahl</surname><given-names>H</given-names></name>
<name><surname>Bodin</surname><given-names>A</given-names></name>
<etal/></person-group>. <article-title>In vivo biocompatibility of bacterial cellulose</article-title>. <source>J Biomed Mater Res A</source> <year>2006</year>; <volume>76</volume>: <fpage>431</fpage>–<lpage>438</lpage>.</citation>
</ref>
<ref id="bibr29-0883911512467643">
<label>29.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Mendes</surname><given-names>PN</given-names></name>
<name><surname>Rahal</surname><given-names>SC</given-names></name>
<name><surname>Pereira-Junior</surname><given-names>OC</given-names></name>
<etal/></person-group>. <article-title>In vivo and in vitro evaluation of an Acetobacter xylinum synthesized microbial cellulose membrane intended for guided tissue repair</article-title>. <source>Acta Vet Scand</source> <year>2009</year>; <volume>51</volume>: <fpage>12</fpage></citation>
</ref>
<ref id="bibr30-0883911512467643">
<label>30.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Pertile</surname><given-names>RA</given-names></name>
<name><surname>Moreira</surname><given-names>S</given-names></name>
<name><surname>Costa</surname><given-names>RM</given-names></name>
<etal/></person-group>. <article-title>Bacterial cellulose: long-term biocompatibility studies</article-title>. <source>J Biomater Sci Polym Ed</source> <year>2012</year>; <volume>23</volume>: <fpage>1339</fpage>–<lpage>1354</lpage>.</citation>
</ref>
<ref id="bibr31-0883911512467643">
<label>31.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wippermann</surname><given-names>J</given-names></name>
<name><surname>Schumann</surname><given-names>D</given-names></name>
<name><surname>Klemm</surname><given-names>D</given-names></name>
<etal/></person-group>. <article-title>Preliminary results of small arterial substitute performed with a new cylindrical biomaterial composed of bacterial cellulose</article-title>. <source>Eur J Vasc Endovasc Surg</source> <year>2009</year>; <volume>37</volume>: <fpage>592</fpage>–<lpage>596</lpage>.</citation>
</ref>
<ref id="bibr32-0883911512467643">
<label>32.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Czaja</surname><given-names>WK</given-names></name>
<name><surname>Young</surname><given-names>DJ</given-names></name>
<name><surname>Kawecki</surname><given-names>M</given-names></name>
<etal/></person-group>. <article-title>The future prospects of microbial cellulose in biomedical applications</article-title>. <source>Biomacromolecules</source> <year>2007</year>; <volume>8</volume>: <fpage>1</fpage>–<lpage>12</lpage>.</citation>
</ref>
<ref id="bibr33-0883911512467643">
<label>33.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Andrade</surname><given-names>FK</given-names></name>
<name><surname>Moreira</surname><given-names>SM</given-names></name>
<name><surname>Domingues</surname><given-names>L</given-names></name>
<etal/></person-group>. <article-title>Improving the affinity of fibroblasts for bacterial cellulose using carbohydrate-binding modules fused to RGD</article-title>. <source>J Biomed Mater Res A</source> <year>2010</year>; <volume>92</volume>: <fpage>9</fpage>–<lpage>17</lpage>.</citation>
</ref>
<ref id="bibr34-0883911512467643">
<label>34.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Putra</surname><given-names>A</given-names></name>
<name><surname>Kakugo</surname><given-names>A</given-names></name>
<name><surname>Furukawa</surname><given-names>H</given-names></name>
<etal/></person-group>. <article-title>Tubular bacterial cellulose gel with oriented fibrils on the curved surface</article-title>. <source>Polymer</source> <year>2008</year>; <volume>49</volume>: <fpage>1885</fpage>–<lpage>1891</lpage>.</citation>
</ref>
<ref id="bibr35-0883911512467643">
<label>35.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Backdahl</surname><given-names>H</given-names></name>
<name><surname>Esguerra</surname><given-names>M</given-names></name>
<name><surname>Delbro</surname><given-names>D</given-names></name>
<etal/></person-group>. <article-title>Engineering microporosity in bacterial cellulose scaffolds</article-title>. <source>J Tissue Eng Regen Med</source> <year>2008</year>; <volume>2</volume>: <fpage>320</fpage>–<lpage>330</lpage>.</citation>
</ref>
<ref id="bibr36-0883911512467643">
<label>36.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bodin</surname><given-names>A</given-names></name>
<name><surname>Backdahl</surname><given-names>H</given-names></name>
<name><surname>Fink</surname><given-names>H</given-names></name>
<etal/></person-group>. <article-title>Influence of cultivation conditions on mechanical and morphological properties of bacterial cellulose tubes</article-title>. <source>Biotechnol Bioeng</source> <year>2007</year>; <volume>97</volume>: <fpage>425</fpage>–<lpage>434</lpage>.</citation>
</ref>
<ref id="bibr37-0883911512467643">
<label>37.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sanchavanakit</surname><given-names>N</given-names></name>
<name><surname>Sangrungraungroj</surname><given-names>W</given-names></name>
<name><surname>Kaomongkolgit</surname><given-names>R</given-names></name>
<etal/></person-group>. <article-title>Growth of human keratinocytes and fibroblasts on bacterial cellulose film</article-title>. <source>Biotechnol Prog</source> <year>2006</year>; <volume>22</volume>: <fpage>1194</fpage>–<lpage>1199</lpage>.</citation>
</ref>
<ref id="bibr38-0883911512467643">
<label>38.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>McKenna</surname><given-names>BA</given-names></name>
<name><surname>Mikkelsen</surname><given-names>D</given-names></name>
<name><surname>Wehr</surname><given-names>JB</given-names></name>
<etal/></person-group>. <article-title>Mechanical and structural properties of native and alkali-treated bacterial cellulose produced by Gluconacetobacter xylinus strain ATCC 53524</article-title>. <source>Cellulose</source> <year>2009</year>; <volume>16</volume>: <fpage>1047</fpage>–<lpage>1055</lpage>.</citation>
</ref>
<ref id="bibr39-0883911512467643">
<label>39.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Pukacki</surname><given-names>F</given-names></name>
<name><surname>Jankowski</surname><given-names>T</given-names></name>
<name><surname>Gabriel</surname><given-names>M</given-names></name>
<etal/></person-group>. <article-title>The mechanical properties of fresh and cryopreserved arterial homografts</article-title>. <source>Eur J Vasc Endovasc Surg</source> <year>2000</year>; <volume>20</volume>: <fpage>21</fpage>–<lpage>24</lpage>.</citation>
</ref>
<ref id="bibr40-0883911512467643">
<label>40.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Purinya</surname><given-names>BA</given-names></name>
<name><surname>Knets</surname><given-names>IV</given-names></name>
<name><surname>Kas’yanov</surname><given-names>VA</given-names></name>
</person-group>. <article-title>Autogenous vein transplants in reconstructive vascular surgery</article-title>. <source>Mech Compos Mater 1975</source>; <volume>11</volume>: <fpage>133</fpage>–<lpage>138</lpage>.</citation>
</ref>
<ref id="bibr41-0883911512467643">
<label>41.</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Martins</surname><given-names>CL</given-names></name></person-group>. <article-title>Appendix B: Properties of soft Materials</article-title>. In: <person-group person-group-type="editor">
<name><surname>Ratner</surname><given-names>BD</given-names></name>
<name><surname>Hoffman</surname><given-names>AS</given-names></name>
<name><surname>Schoen</surname><given-names>FJ</given-names></name><etal/></person-group>. (eds) <source>Biomaterial science: an introduction to materials in medicine</source>. <edition>2nd ed</edition>. <publisher-loc>London</publisher-loc>: <publisher-name>Academic press</publisher-name>, <year>2004</year>, pp. <fpage>819</fpage>–<lpage>820</lpage>.</citation>
</ref>
<ref id="bibr42-0883911512467643">
<label>42.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Heilshorn</surname><given-names>SC</given-names></name>
<name><surname>Liu</surname><given-names>JC</given-names></name>
<name><surname>Tirrell</surname><given-names>DA</given-names></name>
</person-group>. <article-title>Cell-binding domain context affects cell behavior on engineered proteins</article-title>. <source>Biomacromolecules</source> <year>2005</year>; <volume>6</volume>: <fpage>318</fpage>–<lpage>323</lpage>.</citation>
</ref>
<ref id="bibr43-0883911512467643">
<label>43.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kurihara</surname><given-names>H</given-names></name>
<name><surname>Nagamune</surname><given-names>T</given-names></name>
</person-group>. <article-title>Cell adhesion ability of artificial extracellular matrix proteins containing a long repetitive Arg-Gly-Asp sequence</article-title>. <source>J Biosci Bioeng</source> <year>2005</year>; <volume>100</volume>: <fpage>82</fpage>–<lpage>87</lpage>.</citation>
</ref>
<ref id="bibr44-0883911512467643">
<label>44.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Cavalcanti-Adam</surname><given-names>EA</given-names></name>
<name><surname>Volberg</surname><given-names>T</given-names></name>
<name><surname>Micoulet</surname><given-names>A</given-names></name>
<etal/></person-group>. <article-title>Cell spreading and focal adhesion dynamics are regulated by spacing of integrin ligands</article-title>. <source>Biophys J</source> <year>2007</year>; <volume>92</volume>: <fpage>2964</fpage>–<lpage>2974</lpage>.</citation>
</ref>
<ref id="bibr45-0883911512467643">
<label>45.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Singer</surname><given-names>I</given-names></name>
<name><surname>Kazazis</surname><given-names>DM</given-names></name>
<name><surname>Scott</surname><given-names>S</given-names></name>
</person-group>. <article-title>Scanning electron microscopy of focal contacts on the substratum attachment surface of fibroblasts adherent to fibronectin</article-title>. <source>J Cell Sci</source> <year>1989</year>; <volume>93</volume>(<issue>Pt 1</issue>): <fpage>147</fpage>–<lpage>154</lpage>.</citation>
</ref>
<ref id="bibr46-0883911512467643">
<label>46.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hood</surname><given-names>JD</given-names></name>
<name><surname>Cheresh</surname><given-names>DA</given-names></name>
</person-group>. <article-title>Role of integrins in cell invasion and migration</article-title>. <source>Nat Rev Cancer</source> <year>2002</year>; <volume>2</volume>: <fpage>91</fpage>–<lpage>100</lpage>.</citation>
</ref>
<ref id="bibr47-0883911512467643">
<label>47.</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Gallin</surname><given-names>JI</given-names></name>
<name><surname>Synderman</surname><given-names>R</given-names></name>
</person-group>. <source>Inflammation: basic principles and clinical correlates</source>. <edition>3rd ed.</edition> <publisher-name>Lippincott Williams &amp; Wilkins</publisher-name>, <publisher-loc>Philadelphia, PA</publisher-loc>, <year>1999</year>, p. <fpage>1335</fpage>.</citation>
</ref>
<ref id="bibr48-0883911512467643">
<label>48.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Johnston</surname><given-names>RB</given-names></name>
</person-group>. <article-title>Current concepts: immunology. Monocytes and macrophages</article-title>. <source>N Engl J Med</source> <year>1988</year>; <volume>318</volume>: <fpage>747</fpage>–<lpage>752</lpage>.</citation>
</ref>
<ref id="bibr49-0883911512467643">
<label>49.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Rae</surname><given-names>T</given-names></name>
</person-group>. <article-title>The macrophage response to implant materials – with special reference to those used in orthopedics</article-title>. <source>Crit Rev Biocompat</source> <year>1986</year>; <volume>2</volume>: <fpage>97</fpage>–<lpage>126</lpage>.</citation>
</ref>
<ref id="bibr50-0883911512467643">
<label>50.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Greisler</surname><given-names>H</given-names></name>
</person-group>. <article-title>Macrophage-biomaterial interactions with bioresorbable vascular prostheses</article-title>. <source>ASAIO Trans</source> <year>1988</year>; <volume>34</volume>: <fpage>1051</fpage>–<lpage>1059</lpage>.</citation>
</ref>
<ref id="bibr51-0883911512467643">
<label>51.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Babensee</surname><given-names>JE</given-names></name>
<name><surname>Anderson</surname><given-names>JM</given-names></name>
<name><surname>McIntire</surname><given-names>LV</given-names></name>
<etal/></person-group>. <article-title>Host response to tissue engineered devices</article-title>. <source>Adv Drug Deliv Rev</source> <year>1998</year>; <volume>33</volume>: <fpage>111</fpage>–<lpage>139</lpage>.</citation>
</ref>
<ref id="bibr52-0883911512467643">
<label>52.</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Anderson</surname><given-names>JM</given-names></name>
<name><surname>Gristina</surname><given-names>AG</given-names></name>
<name><surname>Hanson</surname><given-names>SR</given-names></name><etal/></person-group>. <article-title>Host reactions to biomaterials and their evaluation</article-title> In: <person-group person-group-type="editor">
<name><surname>Ratner</surname><given-names>BD</given-names></name>
<name><surname>Hoffman</surname><given-names>AS</given-names></name>
<name><surname>Schoen</surname><given-names>FJ</given-names></name><etal/></person-group>. (eds) <source>Biomaterial science: an introduction to materials in medicine</source>. <publisher-loc>London</publisher-loc>: <publisher-name>Academic press</publisher-name>, <year>1996</year>, pp.<fpage>171</fpage>.</citation>
</ref>
<ref id="bibr53-0883911512467643">
<label>53.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Anderson</surname><given-names>JM</given-names></name>
<name><surname>Rodriguez</surname><given-names>A</given-names></name>
<name><surname>Chang</surname><given-names>DT</given-names></name>
</person-group>. <article-title>Foreign body reaction to biomaterials</article-title>. <source>Semin Immunol</source> <year>2008</year>; <volume>20</volume>: <fpage>86</fpage>–<lpage>100</lpage>.</citation>
</ref>
<ref id="bibr54-0883911512467643">
<label>54.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Martson</surname><given-names>M</given-names></name>
<name><surname>Viljanto</surname><given-names>J</given-names></name>
<name><surname>Hurme</surname><given-names>T</given-names></name>
<etal/></person-group>. <article-title>Is cellulose sponge degradable or stable as implantation material? An in vivo subcutaneous study in the rat</article-title>. <source>Biomaterials</source> <year>1999</year>; <volume>20</volume>: <fpage>1989</fpage>–<lpage>1995</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>